ProPhase Labs Analyst Ratings
ProPhase Labs Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 127.64% | HC Wainwright & Co. | → $14 | Reiterates | Buy → Buy |
| 06/02/2023 | 127.64% | HC Wainwright & Co. | → $14 | Reiterates | Buy → Buy |
| 05/12/2023 | 127.64% | HC Wainwright & Co. | $15 → $14 | Maintains | Buy |
| 03/08/2023 | 143.9% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 02/23/2023 | 143.9% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 02/16/2023 | 143.9% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 02/07/2023 | 143.9% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 11/11/2022 | 143.9% | HC Wainwright & Co. | $14 → $15 | Maintains | Buy |
| 05/17/2022 | 127.64% | HC Wainwright & Co. | $16 → $14 | Maintains | Buy |
| 03/31/2022 | 160.16% | HC Wainwright & Co. | $15 → $16 | Maintains | Buy |
| 01/14/2022 | 143.9% | HC Wainwright & Co. | $12 → $15 | Maintains | Buy |
| 12/20/2021 | 95.12% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
| 10/13/2021 | — | Dawson James | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月14日 | 127.64% | HC Wainwright公司 | →$14 | 重申 | 購買→購買 |
| 06/02/2023 | 127.64% | HC Wainwright公司 | →$14 | 重申 | 購買→購買 |
| 2023年05月12日 | 127.64% | HC Wainwright公司 | $15→$14 | 維護 | 買 |
| 03/08/2023 | 143.9% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 02/23/2023 | 143.9% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 02/16/2023 | 143.9% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 02/07/2023 | 143.9% | HC Wainwright公司 | →$15 | 重申 | →購買 |
| 2022年11月11日 | 143.9% | HC Wainwright公司 | $14→$15 | 維護 | 買 |
| 2022/05/17 | 127.64% | HC Wainwright公司 | $16→$14 | 維護 | 買 |
| 03/31/2022 | 160.16% | HC Wainwright公司 | $15→$16 | 維護 | 買 |
| 2022年01月14日 | 143.9% | HC Wainwright公司 | $12→$15 | 維護 | 買 |
| 12/20/2021 | 95.12% | HC Wainwright公司 | →$12 | 開始承保 | →購買 |
| 10/13/2021 | - | 道森·詹姆斯 | 評級下調 | 購買→中性 |
What is the target price for ProPhase Labs (PRPH)?
前期實驗室(PRPH)的目標價格是多少？
The latest price target for ProPhase Labs (NASDAQ: PRPH) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $14.00 expecting PRPH to rise to within 12 months (a possible 127.64% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright&Co.於2023年8月14日報告了前期實驗室(納斯達克：PRPH)的最新目標價。這家分析公司將目標價定為14美元，預計PRPH將在12個月內上漲至(可能上漲127.64%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for ProPhase Labs (PRPH)?
前期實驗室(PRPH)的最新分析師評級是多少？
The latest analyst rating for ProPhase Labs (NASDAQ: PRPH) was provided by HC Wainwright & Co., and ProPhase Labs reiterated their buy rating.
前期實驗室(納斯達克代碼：PRPH)的最新分析師評級由HC Wainwright&Co.提供，前期實驗室重申其買入評級。
When is the next analyst rating going to be posted or updated for ProPhase Labs (PRPH)?
下一次發佈或更新前期實驗室(PRPH)的分析師評級是什麼時候？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProPhase Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProPhase Labs was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與前期實驗室的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。對前期實驗室的最後一次評級是在2023年8月14日提交的，所以你應該預計下一次評級將在2024年8月14日左右提供。
Is the Analyst Rating ProPhase Labs (PRPH) correct?
分析師對前期實驗室(PRPH)的評級正確嗎？
While ratings are subjective and will change, the latest ProPhase Labs (PRPH) rating was a reiterated with a price target of $0.00 to $14.00. The current price ProPhase Labs (PRPH) is trading at is $6.15, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的前期實驗室(PRPH)評級被重申，目標價在0.00美元至14.00美元之間。前期實驗室(PRPH)目前的交易價格為6.15美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。